title: Vilazodone hydrochloride, linagliptin, and alcaftadine.
authors.affiliation: Philadelphia College of Pharmacy, University of Sciences in Philadelphia, PA, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Julie
authors.initials: J
authors.lastname: Samuel
mesh_terms: D001552:Benzazepines / Q000009:adverse effects* / Q000627:therapeutic use*; D001572:Benzofurans / Q000009:adverse effects* / Q000627:therapeutic use*; D003233:Conjunctivitis, Allergic / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use*; D000069476:Linagliptin; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D011687:Purines / Q000009:adverse effects* / Q000627:therapeutic use*; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use*; D000069503:Vilazodone Hydrochloride
chemical_list: D001552:Benzazepines; D001572:Benzofurans; D007093:Imidazoles; D007211:Indoles; D010879:Piperazines; D011687:Purines; D011799:Quinazolines; D000069476:Linagliptin; C557708:alcaftadine; D000069503:Vilazodone Hydrochloride